INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines

NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against NowRx, Inc. ("NowRx" or the "Company"). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether NowRx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until January 23, 2026 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired NowRx securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

[Click here for information about joining the class action]

A complaint has been filed on behalf of NowRx investors, alleging that NowRx and other defendants failed to disclose: (1) material, adverse facts concerning NowRx's financial condition; (2) that NowRx was on the brink of bankruptcy or insolvency; (3) that NowRx had hired an investment bank to explore a sale or raise significant funds so that it could continue operations; (4) that as of December 31, 2021, NowRx was itself valued by an investment bank at $3.55 per share and this $3.55 per share price was significantly less than the $10.50 per share offering price in the Company's Series C stock offering in 2022; and (5) as a result, investors in the Series C stock offering would likely lose their investment.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP